Cover Image

Association Between ABCB1 Polymorphism and Stable Warfarin Dose Requirements in Brazilian Patients

The ideal dose of the oral anticoagulant warfarin varies widely among patients, mainly due to genetic factors. Genetic variations that impact warfarin pharmacokinetics and the vitamin K cycle are plausible candidates for being associated with warfarin dose requirements. Therefore, the aim of this st...

Full description

Saved in:

Bibliographic Details
Main Authors:	Letícia C. Tavares (Author), Leiliane R. Marcatto (Author), Renata A. G. Soares (Author), Jose E. Krieger (Author), Alexandre C. Pereira (Author), Paulo C. J. L. Santos (Author)
Format:	Book
Published:	Frontiers Media S.A., 2018-05-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Machine Learning for Prediction of Stable Warfarin Dose in US Latinos and Latin Americans
by: Heidi E. Steiner, et al.
Published: (2021)

<it>CYP2C19 </it>and <it>ABCB1 </it>gene polymorphisms are differently distributed according to ethnicity in the Brazilian general population
by: Mill José G, et al.
Published: (2011)

Implications of Polymorphisms in the BCKDK and GATA‐4 Gene Regions on Stable Warfarin Dose in African Americans
by: Salma A. Bargal, et al.
Published: (2021)

Multi‐site Investigation of Genetic Determinants of Warfarin Dose Variability in Latinos
by: Nihal El Rouby, et al.
Published: (2021)

Pharmaceutical Care Increases Time in Therapeutic Range of Patients With Poor Quality of Anticoagulation With Warfarin
by: Leiliane Rodrigues Marcatto, et al.
Published: (2018)

Effects of Polymorphisms in Myc-Related Genes on Bleeding Complications in Patients with Stable Warfarin Responses
by: Jeong Yee, et al.
Published: (2019)

Evaluation of the Long-Term Impact on Quality After the End of Pharmacist-Driven Warfarin Therapy Management in Patients With Poor Quality of Anticoagulation Therapy
by: Leiliane Rodrigues Marcatto, et al.
Published: (2020)

Genomewide association analysis of warfarin dose requirements in Middle Eastern and North African populations
by: Nihal El Rouby, et al.
Published: (2022)

Stable warfarin dose prediction in sub‐Saharan African patients: A machine‐learning approach and external validation of a clinical dose-initiation algorithm
by: Innocent G. Asiimwe, et al.
Published: (2022)

The Impact of ABCB1 and CES1 Polymorphisms on Dabigatran Pharmacokinetics in Healthy Chinese Subjects
by: Liu Y, et al.
Published: (2021)

The effect of ABCB1 polymorphisms on the outcome of breast cancer treatment
by: Tulsyan S, et al.
Published: (2016)

Warfarin dose requirement and cytochrome P450 2C9 and Vitamin K epoxide reductase complex subunit 1-1639 genetic polymorphisms in Thai patients
by: Burassakorn Subsuphan, et al.
Published: (2016)

Association between ABCB1 Gene Polymorphisms and Labor Analgesia in Primiparas
by: Wei Li, et al.
Published: (2024)

The Influence of Ethnicity on Warfarin Dosage Requirements in the Chilean Population
by: Valeska Subiabre, MsCs, et al.
Published: (2015)

VKORC1, CYP2C9 Polymorphisms and clotting factors associated with warfarin maintenance dose
by: Alisara Sangviroon
Published: (2014)

Parameters Associated with the Required Drug Dose of Intravenous Immunoglobulin in Stable Chronic Inflammatory Demyelinating Polyradiculoneuropathy
by: Ludger Feyen, et al.
Published: (2023)

Effect of age and sex on warfarin dosing
by: Khoury G, et al.
Published: (2014)

ABCB1 and ABCC1 single-nucleotide polymorphisms in patients treated with clozapine
by: Piatkov I, et al.
Published: (2017)

Creating and validating a warfarin pharmacogenetic dosing algorithm for Colombian patients
by: Galvez JM, et al.
Published: (2018)

Pharmacogenetics-based population pharmacokinetic analysis and dose optimization of valproic acid in Chinese southern children with epilepsy: Effect of ABCB1 gene polymorphism
by: Xianhuan Shen, et al.
Published: (2022)

VKORC1 variants as significant predictors of warfarin dose in Emiratis
by: Al-Mahayri ZN, et al.
Published: (2019)

<it>SLCO1B1 </it>rs4149056 polymorphism associated with statin-induced myopathy is differently distributed according to ethnicity in the Brazilian general population: Amerindians as a high risk ethnic group
by: Krieger José E, et al.
Published: (2011)

Influence of CYP450 Enzymes and ABCB1 Polymorphisms on Clopidogrel Response in Moroccan Patients with Acute Coronary Syndromes
by: Mouhrach I, et al.
Published: (2023)

Population pharmacokinetic study of the effect of polymorphisms in the ABCB1 and CES1 genes on the pharmacokinetics of dabigatran
by: Zhuan Yang, et al.
Published: (2024)

Association of ABCB1 Polymorphisms with Efficacy and Adverse Drug Reactions of Valproic Acid in Children with Epilepsy
by: Jiahao Zhu, et al.
Published: (2023)

Influence of NQO1 Polymorphisms on Warfarin Maintenance Dose: A Systematic Review and Meta-Analysis (rs1800566 and rs10517)
by: Lihong Tian, et al.
Published: (2021)

Role of ABCB1 and ABCB4 in renal and biliary excretion of perfluorooctanoic acid in mice
by: Kazuyoshi Furukawa, et al.
Published: (2024)

Differing temperature dependencies of functional homologs zebrafish Abcb4 and human ABCB1
by: Till Luckenbach, et al.
Published: (2024)

Influence of ABCB1 Gene Polymorphism on Rivaroxaban Blood Concentration and Hemorrhagic Events in Patients With Atrial Fibrillation
by: Yan Wang, et al.
Published: (2021)

GSTP1 and ABCB1 Polymorphisms Predicting Toxicities and Clinical Management on Carboplatin and Paclitaxel‐Based Chemotherapy in Ovarian Cancer
by: Amanda Canato Ferracini, et al.
Published: (2021)

Association of CYP3A4/5, ABCB1 and ABCC2 polymorphisms and clinical outcomes of Thai breast cancer patients treated with tamoxifen
by: Sensorn I, et al.
Published: (2013)

Effects of coagulation factor VII polymorphisms on warfarin sensitivity and responsiveness in Jordanian cardiovascular patients during the initiation and maintenance phases of warfarin therapy
by: AL-Eitan LN, et al.
Published: (2019)

Polymorphisms of VKORC1 and CYP2C9 are associated with warfarin sensitivity in Chinese population
by: Jia LQ, et al.
Published: (2017)

Influence of CYP2D6, CYP3A5, ABCB1, APOE polymorphisms and nongenetic factors on donepezil treatment in patients with Alzheimer’s disease and vascular dementia
by: Yaowaluk T, et al.
Published: (2019)

Influence of <i>ABCB1</i> <i>3435C>T</i> polymorphism on methotrexate safety in patients with psoriasis
by: Alexey A. Kubanov, et al.
Published: (2023)

Meta-Analysis of ABCG2 and ABCB1 Polymorphisms With Sunitinib-Induced Toxicity and Efficacy in Renal Cell Carcinoma
by: Fengjun Sun, et al.
Published: (2021)

Pharmacogenetic Study of the Impact of <i>ABCB1</i> Single Nucleotide Polymorphisms on the Response to Cyclosporine in Psoriasis Patients
by: Alexandr Chernov, et al.
Published: (2022)

Use of low-dose oral warfarin in three cases of livedoid vasculopathy
by: Vikrant Saoji, et al.
Published: (2017)

Genetic factors associated with patient-specific warfarin dose in ethnic Indonesians
by: Utama Andi, et al.
Published: (2011)

Taste-Masked Pellets of Warfarin Sodium: Formulation towards the Dose Personalisation
by: Lakija Kovalenko, et al.
Published: (2024)